1-3 of 3
Fred Behm
Close
Save search
Sort by
Journal Articles

TBI and Allogeneic BMT Do Not Appear To Hinder Growth in Pediatirc Patients with AML Treated on POG 9421 (Now Children’s Oncology Group).

Free
Kimo Stine, MD, David Becton, MD, Gary Van Houten Dahl, MD, Yaddanapudi Ravindranath, MD, Susana C. Raimondi, PhD, Fred Behm, MD, Myron Chang, Robert Arceci, MD
Journal: Blood
Blood (2006) 108 (11): 3677.
https://doi.org/10.1182/blood.V108.11.3677.3677
Published: 2006
Journal Articles

Prognostic Significance of CD20 in Children with B-Precursor Acute Lymphoblastic Leukemia.

Free
Sima Jeha, MD, Cheng Cheng, PhD, John Sandlund, MD, Raul Ribeiro, MD, Bassem Razzouk, MD, Jeffrey Rubnitz, MD, Nobuko Hijiya, MD, Scott Howard, MD, Fred Behm, MD, Ching-Hon Pui, MD
Journal: Blood
Blood (2005) 106 (11): 1452.
https://doi.org/10.1182/blood.V106.11.1452.1452
Published: 2005
Journal Articles

Monoclonal Antibodies Specific to the Acute Lymphoblastic Leukemia t(1; 19)-Associated E2A/pbx1 Chimeric Protein: Characterization and Diagnostic Utility

Free
Bi-Ching Sang, Liangru Shi, Peter Dias, Li Liu, Jia Wei, Zhi-Xue Wang, Craig R. Monell, Fred Behm, Stefan Gruenwald
Journal: Blood
Blood (1997) 89 (8): 2909–2914.
https://doi.org/10.1182/blood.V89.8.2909
Published: 1997